Efendioglu, M. Et Al. 2021. Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2 , 133-136.

Efendioglu, M., Sanli, E., Turkoglu, C., & Balak, N., (2021). Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2, 133-136.

Efendioglu, Mustafa Et Al. "Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis," NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2, 133-136, 2021

Efendioglu, Mustafa Et Al. "Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis." NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2, pp.133-136, 2021

Efendioglu, M. Et Al. (2021) . "Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis." NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2, pp.133-136.

@article{article, author={Mustafa Efendioglu Et Al. }, title={Reduced Serum sRANKL and sTREM2 Levels in High-Grade Gliomas: Association with Prognosis}, journal={NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY}, year=2021, pages={133-136} }